Skip to main content
. 2017 Dec 16;9(24):17141–17148. doi: 10.18632/oncotarget.23839

Table 2. Prognostic features and their potential targets of miRNAs.

Author (Year) Cut-off
value
Follow- up
(month)
miRNA Sample size Reference OS Potential targets Expression associates with poor prognosis
HR (95% CI) P
S. Azizmohammadi
(2016)
Median
(NA)
60 miRNA-145 35 L:H a 2.62
(1.134–6.362)
0.031 _ Low
Fan (2015) Mean
(NA)
42 miRNA-125a 55 H:L b 0.691
(0.418–1.141)
_ STAT3 Low
Wang (2015) Median (2.5) median 47 miRNA-145 114 H:L a 0.63
(0.54–0.83)
0.008 _ Low
Liu (2015) Mean (3.880) 80 miRNA-196a 105 H:L a 3.510
(1.961–6.874)
0.025 _ high
Hou (2013) Median
(NA)
median 45.6
(1.2–60)
miRNA-196a 92 L:H b 0.266
(0.028–2.542)
_ FOXO1 and p27Kip1 high
Huang (2012) Mean (3.871) mean 23.6 miRNA-125b 44 H:L a 0.352
(0.102–1.014)
0.057 _ low
Huang (2012) Mean
(8.941)
mean 23.6 miRNA-145 44 H:L c 0.58
(0.32–1.05)
0.072 _ low

NA, not available; L, low expression of miRNA; H, high expression of miRNA; a extracted from multivariate analyses; b estimated base on Kaplan-Meier survival curves; c extracted from univariate analyses.